CHEK2 and breast carcinoma: According to the National Comprehensive Cancer Network (NCCN) guidelines, a woman with a germline CHEK2 pathogenic variant has an estimated 15–40% overall risk of breast cancer, and an annual mammogram and consideration of tomosynthesis and breast MRI with contrast were recommended for the patient in our case.